Company intelligence
International Rare Diseases Research Consortium (IRDiRC)
About International Rare Diseases Research Consortium (IRDiRC)
The International Rare Diseases Research Consortium (IRDiRC) is a global collaborative initiative launched in 2011 by the European Commission and the US National Institutes of Health to tackle rare diseases through research and accomplish the vision to enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention.
Verified activity
Signals from International Rare Diseases Research Consortium (IRDiRC)
4 published signals
Presence & Recognition
International Rare Diseases Research Consortium (IRDiRC) is hosting a public workshop on 29 September 2026 titled Rethinking Clinical Delivery, Regulation, and Payment Models for Individualized Platform-Based Genome Editing Therapies.
Reported by International Rare Diseases Research Consortium (IRDiRC)
Presence & Recognition
International Rare Diseases Research Consortium (IRDiRC) is hosting a multistakeholder workshop on real-world data collection in Duchenne muscular dystrophy at the European Medicines Agency on 25 September 2026.
Reported by International Rare Diseases Research Consortium (IRDiRC)
Presence & Recognition
International Rare Diseases Research Consortium (IRDiRC) is hosting three upcoming ERDERA webinars on Public-Private Collaboration, Diagnostic Research, and Regulatory Insights.
Reported by International Rare Diseases Research Consortium (IRDiRC)
Presence & Recognition
International Rare Diseases Research Consortium (IRDiRC) announced that the Rare Care Centre in Western Australia commenced its Pilbara Hub clinics bringing cross-sector rare disease care coordination to communities up to 1,500 kilometres from Perth, Australia.
Reported by International Rare Diseases Research Consortium (IRDiRC)